Full-Time

Oncology Franchise Launch Excellence Lead

Flex

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA + 1 more

More locations: Morristown, NJ, USA

Candidates must be US and Puerto Rico residents.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Agile
Requirements
  • 10+ years in Commercial roles, leading launches and/or launch excellence.
  • 5+ years in leading cross functional teams
  • 2+ years of Global experience
  • 2+ years of Local Country experience
  • Deep understanding of launch excellence drivers, launch readiness framework and building BIC capabilities
  • In-depth understanding of pharmaceutical industry
  • Experienced in leading by influence and drive in matrix driven project teams/organizations.
  • Agile mindset and practice: ensure the correct pace of the acceleration being outcome goal oriented.
  • Ability to leverage networks, to develop people, coach & give feedback, empower people.
  • Ability to lead change while achieving business goals & objectives, act for change - Challenge the status quo. Be persistent and resilient.
  • Commercialization expertise (commercial and/or medical)
  • Oncology experience across tumor types and launches
  • Launch excellence
  • Strategic analysis and planning, project management, excellent English language knowledge and skills (written and oral), IT knowledge, proven communication, presentation, persuasion skills, ability to work and influence cross-functionally.
Responsibilities
  • Accountable for Best in Class Launches across the Oncology Franchise:
  • Accountable for implementing the New LEx blueprint and framework within the franchise.
  • Launch Plan management (supported by the launch managers, when they exist).
  • Responsible for launch readiness, launch simulations & go-to market operations and cross functional alignment (incl. alliance if applicable).
  • Launch Readiness reviews (LPR) within Global franchise and key markets.
  • GBU level launch governance bodies (ig. ELC)
  • Ensure strong coordination through GBT.
  • Monthly KPI reporting based on defined metrics cross-franchise.
  • Pulls through Global launch frameworks and templates for market.
  • Drive launch Excellence across Sanofi being and active member and strong partner of Global launch Excellence.
  • Develops, maintains, and tracks launch plans for launch products supported by key performance indicators.
  • Maximizes synergies from launch to launch and ensures the lessons learned from launch experience are leveraged for future launches.
  • Deliver the change management milestones to support the new structure.
  • Support global brand team by providing clarity on the ambition for a BiC launch organization, providing Launch expertise and addressing capability gaps towards defined global LEX excellence standards in close partnership with business.
  • Elevate Sanofi launch readiness, implementing launch readiness governance and coordinating the launch readiness process at global level.
  • Drive launch innovation.
  • Participate in the implementation, in partnership with the digital teams, an enhanced digital ecosystem and AI Led technologies to support BiC launches, translated in clear market competitive advantage.
  • Partner with Launch and Commercialization Academy in the development of launch curriculum to upskill the launch community and brand teams in the critical go to market capabilities (existing gaps and new) supporting the team elements in their development journey.
  • Ensure alignment with other functions within the franchise and beyond.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi differentiates itself from competitors by its strong commitment to scientific innovation and a diverse product portfolio that includes prescription medicines and vaccines. Its goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Simplify Jobs

Simplify's Take

What believers are saying

  • Tolebrutinib's FDA Breakthrough Therapy designation boosts Sanofi's neurology portfolio.
  • Dupixent's EU approval for young children expands Sanofi's pediatric market.
  • Sanofi's partnership with BrightInsight accelerates digital health solution development.

What critics are saying

  • Liver enzyme elevations in tolebrutinib patients may affect market acceptance.
  • Increased competition in rare diseases from biotech startups challenges Sanofi.
  • Regulatory delays could impact Dupixent's approval for chronic spontaneous urticaria.

What makes Sanofi unique

  • Sanofi's Care4Rare program supports innovative solutions for rare diseases.
  • The MyWay app enhances patient engagement and medication adherence.
  • Sanofi's Muse AI tool optimizes patient recruitment in clinical trials.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Parental Leave